Access to Medications for Opioid Use Disorder in Urban and Rural Communities: A Scoping Review Protocol [PDF]
, 2021 This is a protocol for a scoping review that seeks to determine the scope of available evidence comparing access to medications for opioid use disorder in urban and rural ...
Erin L. Winstanley +5 more
core +1 more source
Protocol for a scoping review of policies regarding use of medications for opioid use disorder in professional recovery programs [PDF]
, 2021 A scoping review aimed at summarizing current literature which describes policies related to treatment of opioid use disorder with medications within professional recovery programs for physicians, pharmacists, and ...
Lucas Hill, Kelley White
core +1 more source
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone [PDF]
Mental Health Clinician, 2021 Introduction: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop
Lindsay M. Mailloux, PharmD +3 more
doaj +1 more source
Medications for management of opioid use disorder
American Journal of Health-System Pharmacy, 2019 Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings.
Jennifer L, Koehl +2 more
openaire +2 more sources
JAMA Network Open, 2023 This cross-sectional study uses data from the 2021 National Survey on Drug Use and Health to estimate the receipt of medication for opioid use disorder among US adults with past-year opioid use disorder.
Jones, Christopher M. +4 more
openaire +2 more sources
The Lived Experience of Medication for Opioid Use Disorder
Journal of Addictions Nursing, 2023 Abstract Purpose of the Study Buprenorphine and methadone, when used as maintenance therapy in opioid use disorder (OUD), can significantly reduce the risk of death after an opioid overdose. Despite the many benefits, medication for OUD (MOUD) remains controversial and underutilized.
Aimee Techau +3 more
openaire +2 more sources
Educating the community about the opioid epidemic and medications for opioid use disorder
The American Journal on Addictions, 2022 AbstractBackground and ObjectivesDespite overwhelming evidence of benefit, medications for opioid use disorder (MOUD) remain stigmatizing and more efforts are needed to educate health care professionals and the general public.MethodsWe developed and evaluated an educational program for graduate students studying health sciences, teaching them to ...
Jill M. Williams +5 more
openaire +2 more sources
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Mental Health Professionals’ Perception of Medications for Opioid Use Disorder [PDF]
, 2023 Despite the widespread attention and resources allocated to the current opioid crisis, the public health problem persists. A major target in the efforts to combat the opioid crisis is increased accessibility and utilization of medications for opioid use ...
Mullen, Patrick M
core +1 more source
The Concurrent Initiation of Medications Is Associated with Discontinuation of Buprenorphine Treatment for Opioid Use Disorder [PDF]
, 2020 Introduction Retention in buprenorphine treatment for opioid use disorder (OUD) yields better opioid abstinence and reduces all-cause mortality for patients with OUD.
Chiang, Chien-Wei +6 more
core +1 more source